Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05007483 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Diet on Quality of Life in Multiple Sclerosis

Study acronym: EDQ
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 18, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 30 days later Sep 1, 2026 → Oct 1, 2026
See other at-risk trials from Terry L. Wahls

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Sep 1, 2026 to Oct 1, 2026 Show 4 more changesShow less
    • Eligibility criteria expanded, about 21 words
    • Secondary endpoints: details revised at 2 of 35 entries
    • Study description revised
    • Publications: details revised at 10 of 10 entries
  2. Secondary endpoints: details revised at 4 of 35 entriesv12
  3. Primary completion date: Jul 1, 2025 to Sep 1, 2026
    • Primary endpoints: 10 to 7
    • Secondary endpoints: 30 to 35
    • Study description shortened, about 56 words
    v11
  4. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 156 to confirmed 162
    • Site details revised
    v10
  5. Primary completion date: Mar 1, 2025 to Jul 1, 2025
    • Study completion date: Mar 1, 2026 to Dec 1, 2026
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Eligibility criteria shortened, about 2 wordsv8
  2. Interventions: BodyBio Balance Oil (Dietary Supplement), BodyBio PC (Dietary Supplement), Dietary Guidelines for Americans Diet (Behavioral), Kirunal Fish… to BodyBio Balance Oil (Dietary Supplement), BodyBio PC (Dietary Supplement), Kirunal Fish Oil (Dietary Supplement), Modified Paleolithic…
    • Eligibility criteria shortened, about 31 words
    v7
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 1, 2022 to Feb 10, 2022
    • Site details revised
    v6
  4. Start date: Dec 1, 2021 to Mar 1, 2022
    • Primary completion date: Dec 1, 2025 to Mar 1, 2025
    • Study completion date: Dec 1, 2026 to Mar 1, 2026
    v5
  5. Primary endpoints: 8 to 10
    • Secondary endpoints: 19 to 30
    • Eligibility criteria shortened, about 1 word
    • Study description expanded, about 2 words
    v4
  6. Eligibility criteria shortened, about 45 wordsv3
  7. Eligibility criteria shortened, about 162 words
    • Secondary endpoints: details revised at 2 of 19 entries
    • Study description revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overarching goal of this project is to critically evaluate the efficacy of incorporating dietary guidance within multiple sclerosis (MS) care for improving long-term quality of life (QoL) compared to usual care. The primary objective of this study is to evaluate the effect of two dietary interventions (time restricted olive oil based (TROO) ketogenic and modified Paleolithic elimination) on MS QoL compared to usual care control (Dietary Guidelines for America), and the secondary objectives and the long-term effects on, motor function, low-contrast vision sensitivity, fatigue, mood, and disease activity assessed by brain imaging.
Trial Details
NCT Number NCT05007483
Lead Sponsor Terry L. Wahls
Conditions
(from sponsor)		 Multiple Sclerosis, Relapsing-Remitting
Related terms Fatigue, Multiple Sclerosis, Relapsing-Remitting
Enrollment 162 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov